EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieLeitlinieOpen Access · CC BY 4.0

Feasibility of ERAS guidelines for cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CRS-HIPEC): An international multicenter study

Amaniel Kefleyesus, Vahan Képénékian, Naoual Bakrin, Laurent Villeneuve, Guillaume Passot, Eddy Cotte, Jennifer Mateshaytis, Prafull Ghatage, Lloyd Mack, Antoine Bouchard-Fortier, Melina Deban, Manuela Robella und 23 weitere

European Journal of Surgical Oncology · 2026

DOI: 10.1016/j.ejso.2026.111452 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Surgical Oncology, 2026. Verfasst von Amaniel Kefleyesus und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of visceral surgery, Lausanne University Hospital and University of Lausanne, Switzerland. Electronic address: amaniel.kefleyesus@chuv.ch. Hauptthemen laut MEDLINE: Hyperthermic Intraperitoneal Chemotherapy, Cytoreduction Surgical Procedures, Enhanced Recovery After Surgery, Ovarian Neoplasms. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lausanne University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Enhanced Recovery After Surgery (ERAS) protocols aim to optimize perioperative care and improve recovery after major surgery. While ERAS pathways are well established in several oncologic disciplines, their feasibility and consistency in the setting of cytoreductive surgery, with or without hyperthermic intraperitoneal chemotherapy (CRS ± HIPEC), remain uncertain due to the complexity and heterogeneity of these procedures. METHODS: A prospective multicenter observational study was conducted across 10 expert CRS-HIPEC centers to assess the feasibility and real-world implementation of the ERAS Society guidelines for cytoreductive surgery, with or without hyperthermic intraperitoneal chemotherapy. Perioperative practices were compared before (PRE-ERAS) and after (POST-ERAS) structured ERAS guideline implementation. ERAS adherence, clinical outcomes, and predictors of 90-day postoperative complications and prolonged length of stay were analyzed using multivariable logistic regression models. In addition, a predefined subgroup analysis compared outcomes between ovarian and non-ovarian primary tumors. RESULTS: Between 2021 and 2022, 497 patients were included (PRE-ERAS: 288; POST-ERAS: 209). Baseline characteristics were similar except for more ovarian primaries in POST-ERAS (26.4% vs 44%, p = 0.004). POST-ERAS patients showed higher adherence to anemia screening (60% vs 69%, p = 0.042), carbohydrate loading (4% vs 30%, p 70% ERAS adherence (OR 0.19, 95% CI 0.06-0.54, p = 0.003) predicted fewer complications. Ovarian primary (OR 0.50, 95% CI 0.28-0.87, p = 0.016), >70% adherence (OR 0.33, 95% CI 0.12-0.82, p = 0.025), and POST-ERAS status (OR 0.61, 95% CI 0.37-0.99, p = 0.046) correlated with shorter LOS. CONCLUSION: ERAS implementation for CRS ± HIPEC shortened hospital stay but remained incomplete and was associated with increased readmissions, without reducing complication rates. These findings highlight the need to focus on a pragmatic set of high-impact ERAS elements to improve feasibility in complex cytoreductive surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperthermic Intraperitoneal ChemotherapyCytoreduction Surgical ProceduresEnhanced Recovery After SurgeryOvarian NeoplasmsPractice Guidelines as TopicPeritoneal NeoplasmsHumansFemaleFeasibility StudiesMiddle AgedProspective StudiesLength of StayPostoperative ComplicationsGuideline AdherenceAgedAdultMale

Stichwörter der Autor:innen

Cytoreductive surgeryERASHIPECLength of stayPeritoneal metastasesPostoperative complications

Autor:innen und Institutionen

  • Department of visceral surgery, Lausanne University Hospital and University of Lausanne, Switzerland. Electronic address: amaniel.kefleyesus@chuv.ch.
  • Department of Surgical Oncology, Lyon Sud University Hospital, Hospices civils de Lyon, France; EMR 3738, CICLY, Université Claude Bernard Lyon 1, Lyon, France.
  • Department of Obstetrics and Gynecology, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Department of Surgery, University of Calgary, Calgary, Canada.
  • Department of Surgical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Department of Digestive and Oncological Surgery, Claude Huriez University Hospital; UMR-S127-CANTHER "Cancer Heterogeneity, Plasticity and Resistance to Therapies" Laboratory, Lille, France.

Förderung

  • Lausanne University Hospital

Zitieren

APA

Kefleyesus, A., Képénékian, V., Bakrin, N., Villeneuve, L., Passot, G., Cotte, E., Mateshaytis, J., Ghatage, P., Mack, L., Bouchard-Fortier, A., Deban, M., Robella, M., Eveno, C., Noiret, B., Cirenei, C., Sanders, V., Piessen, G., Teixeira, H., Münster, T., …, & Hübner, M. (2026). Feasibility of ERAS guidelines for cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CRS-HIPEC): An international multicenter study. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2026.111452

Vancouver

Kefleyesus A, Képénékian V, Bakrin N, Villeneuve L, Passot G, Cotte E, et al. Feasibility of ERAS guidelines for cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CRS-HIPEC): An international multicenter study. European Journal of Surgical Oncology. 2026. doi:10.1016/j.ejso.2026.111452

BibTeX
@article{Kefleyesus2026,
  author = {Kefleyesus, Amaniel and Képénékian, Vahan and Bakrin, Naoual and Villeneuve, Laurent and Passot, Guillaume and Cotte, Eddy and Mateshaytis, Jennifer and Ghatage, Prafull and Mack, Lloyd and Bouchard-Fortier, Antoine and Deban, Melina and Robella, Manuela and Eveno, Clarisse and Noiret, Barbara and Cirenei, Cedric and Sanders, Virginie and Piessen, Guillaume and Teixeira, Hugo and Münster, Tino and Piso, Pompiliu and Kr, Ashwin and Kapoor, Priya and Kumar, Rohit and Rakshit, Susmita and Rauthan, Amit and Somashekhar, S P and Wadhwa, Anupama and Ngo, Fallon and Arias, Fernando and Rivard, Justin and Hebbard, Pamela and Bhangu, Manpreet and Nelson, Gregg and Glehen, Olivier and Hübner, Martin},
  title = {Feasibility of ERAS guidelines for cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CRS-HIPEC): An international multicenter study},
  journal = {European Journal of Surgical Oncology},
  year = {2026},
  doi = {10.1016/j.ejso.2026.111452}
}
Kostenlos starten →